Inhibitor Therapeutics (INTI) Total Debt (2013 - 2026)
Inhibitor Therapeutics (INTI) posted Total Debt of $47,828 for Q2 2026, down 38.7% from $78,051 a year earlier and down 18.0% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Total Debt (2013 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics' Total Debt came in at $61,613.
- Annual Total Debt shows a five-year compound annual growth rate of -6.2% (FY2020 to FY2025).
- In prior years, Inhibitor Therapeutics' Total Debt was $411,000 in FY2022 (+77.9%) and $231,000 in FY2021 (+171.6%).
- The Q2 2026 figure stands as the lowest quarterly Total Debt since Q3 2021.
- The strongest year-over-year quarter for Total Debt in the past five years was Q3 2022, with growth of 967.5%; the weakest was Q2 2026, with a decline of 38.7%.
- According to Business Quant data, Total Debt for the three prior quarters was $58,361 (Q1 2026), $61,613 (Q4 2025) and $71,636 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 47,828.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47,828.00 |
| Mar 31, 2026 | 58,361.00 |
| Dec 31, 2025 | 61,613.00 |
| Sep 30, 2025 | 71,636.00 |
| Jun 30, 2025 | 78,051.00 |
| Mar 31, 2025 | 84,348.00 |
| Dec 31, 2022 | 411,000.00 |
| Sep 30, 2022 | 411,000.00 |
| Jun 30, 2022 | 331,000.00 |
| Mar 31, 2022 | 281,000.00 |
| Dec 31, 2021 | 231,000.00 |
| Sep 30, 2021 | 38,500.00 |
| Jun 30, 2021 | 96,250.00 |
| Mar 31, 2021 | 104,000.00 |
| Dec 31, 2020 | 85,044.00 |
| Sep 30, 2020 | 41,600.00 |
| Jun 30, 2020 | 41,600.00 |
| Sep 30, 2014 | 41,920.00 |
| Jun 30, 2014 | 102,420.00 |
| Mar 31, 2014 | 77,701.00 |
API Access
Inhibitor Therapeutics Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();